NO20043295L - Faste salt-benzazepinforbindelser og deres anvendelse ved fremstilling av farmasoytiske forbindelser - Google Patents

Faste salt-benzazepinforbindelser og deres anvendelse ved fremstilling av farmasoytiske forbindelser

Info

Publication number
NO20043295L
NO20043295L NO20043295A NO20043295A NO20043295L NO 20043295 L NO20043295 L NO 20043295L NO 20043295 A NO20043295 A NO 20043295A NO 20043295 A NO20043295 A NO 20043295A NO 20043295 L NO20043295 L NO 20043295L
Authority
NO
Norway
Prior art keywords
compounds
preparation
solid salt
benzazepine
pharmaceutical
Prior art date
Application number
NO20043295A
Other languages
English (en)
Other versions
NO330528B1 (no
Inventor
Paulus Franciscus Corneli Meij
Joris A Van Der Eerden
Paulus Pg De Jong
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of NO20043295L publication Critical patent/NO20043295L/no
Publication of NO330528B1 publication Critical patent/NO330528B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20043295A 2002-01-16 2004-08-06 Nye salter av benzazepinforbindelser, fremgangsmater for fremstilling derav, og anvendelse av slike i farmasoytiske sammensetninger NO330528B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02075621 2002-01-16
NL1019762 2002-01-17
PCT/EP2003/000515 WO2003059939A1 (en) 2002-01-16 2003-01-15 Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds

Publications (2)

Publication Number Publication Date
NO20043295L true NO20043295L (no) 2004-08-06
NO330528B1 NO330528B1 (no) 2011-05-09

Family

ID=26077601

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043295A NO330528B1 (no) 2002-01-16 2004-08-06 Nye salter av benzazepinforbindelser, fremgangsmater for fremstilling derav, og anvendelse av slike i farmasoytiske sammensetninger

Country Status (15)

Country Link
US (1) US6998398B2 (no)
EP (1) EP1468010A1 (no)
JP (1) JP4384495B2 (no)
KR (1) KR100979077B1 (no)
CN (1) CN100591689C (no)
AU (1) AU2003206755B2 (no)
BR (1) BR0306701A (no)
CA (1) CA2473447A1 (no)
HR (1) HRP20040560A2 (no)
IL (1) IL162645A0 (no)
MX (1) MXPA04006887A (no)
NO (1) NO330528B1 (no)
PL (1) PL371511A1 (no)
RU (1) RU2303041C2 (no)
WO (1) WO2003059939A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050009031A (ko) * 2003-07-15 2005-01-24 엘지전자 주식회사 1회 기록 가능한 광디스크 및 광디스크의 관리정보 기록방법
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid
AR046454A1 (es) 2003-11-18 2005-12-07 Solvay Pharm Gmbh Uso de un compuesto de acido benzazepin-n-acetico, composicion farmaceutica, y procedimiento para la produccion de dicha composicion farmaceutica
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US7816347B2 (en) 2004-12-15 2010-10-19 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors
US20060159748A1 (en) * 2004-12-23 2006-07-20 Rajesh Jain Oral immediate release formulation of a poorly water-soluble active substance
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
WO2007054975A1 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders
HU227696B1 (en) * 2006-04-13 2011-12-28 Egyt Gyogyszervegyeszeti Gyar Zinc salt of rosuvastatin, process for its preparation and pharmaceutical compositions containing it
PL424452A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu
PL424453A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
DE19750002A1 (de) * 1997-11-12 1999-05-20 Solvay Pharm Gmbh Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen

Also Published As

Publication number Publication date
MXPA04006887A (es) 2004-12-06
RU2004124840A (ru) 2006-01-20
CN100591689C (zh) 2010-02-24
JP4384495B2 (ja) 2009-12-16
AU2003206755A1 (en) 2003-07-30
HK1072946A1 (zh) 2005-09-16
US6998398B2 (en) 2006-02-14
KR100979077B1 (ko) 2010-08-31
NO330528B1 (no) 2011-05-09
PL371511A1 (en) 2005-06-27
JP2005520809A (ja) 2005-07-14
US20050038012A1 (en) 2005-02-17
AU2003206755B2 (en) 2008-07-17
HRP20040560A2 (en) 2004-10-31
EP1468010A1 (en) 2004-10-20
BR0306701A (pt) 2004-12-28
KR20040089106A (ko) 2004-10-20
CA2473447A1 (en) 2003-07-24
IL162645A0 (en) 2005-11-20
CN1617883A (zh) 2005-05-18
WO2003059939A1 (en) 2003-07-24
RU2303041C2 (ru) 2007-07-20

Similar Documents

Publication Publication Date Title
DK1578755T3 (da) Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse
AU2003213606A8 (en) Mp53s as modifiers of the p53 pathway and methods of use
NO20022680L (no) Farmasoytiske kombinasjoner og deres anvendelse ved behandling av gastrointestinale forstyrrelser
NO20040469L (no) Heterocykliske forbindelser samt fremstilling og anvendelse derav
TWI349664B (en) Benzimidazole derivatives: preparation and pharmaceutical applications
NO20053920D0 (no) Preparat for og behandling av demyelineringssykdommer og paralyse ved administrering av remyelineringsmidler.
PL377854A1 (pl) Farmaceutyczne preparaty donosowe oraz sposoby ich stosowania
NO20034169L (no) MCH-antagonister og deres anvendelse ved behandling av fedme
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
NO20043370L (no) N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer
NO20025357D0 (no) Antranylamider og deres anvendelse som legemidler
NO20055652D0 (no) Laktatinneholdende farmasoytisk preparat og anvendelse av dette
ZA200407460B (en) Therapeutic methods and uses of sapogenins and their derivatives
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
NO20035581D0 (no) Farmasöytisk formulering med maskert smak samt fremstilling derav
NO20022022L (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
AU2002314887A1 (en) Gads as modifiers of the p53 pathway and methods of use
NO20054535D0 (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
DE60232445D1 (de) Cetirizin und pseudoephedrin enthaltende tablette
PL1673349T3 (pl) Pochodne benzimidazolu: wytwarzanie i zastosowania farmaceutyczne
DK1353912T3 (da) 2-Arylimino-2,3-dihydrothiazolderivater, fremgangsmåderne til deres fremstilling og deres terapeutiske anvendelse
PL371511A1 (en) Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds
DK1212336T3 (da) Fremgangsmåde til fremstilling af sfæriske agglomerater af telithromycin og deres anvendelse ved fremstilling af farmaceutiske former

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees